Results 291 to 300 of about 444,796 (301)

Dissecting humoral immune responses to an MVA-vectored MERS-CoV vaccine in humans using a systems serology approach. [PDF]

iScience
Weskamm LM, Tarnow P, Harms C, Huchon M, Raadsen MP, Friedrich M, Rübenacker L, Grüttner C, Garcia MG, MVA-MERS-S-CEF study group, Koch T, Becker S, Sutter G, Lhomme E, Haagmans BL, Fathi A, Blois SM, Dahlke C, Richert L, Addo MM.   +19 more
europepmc   +1 more source

Spatial examination of social and environmental drivers of Middle East respiratory syndrome coronavirus (MERS-CoV) across Kenya. [PDF]

Ecohealth
Lawrence TJ, Kangogo GK, Fredman A, Deem SL, Fèvre EM, Gluecks I, Brien JD, Shacham E.   +7 more
europepmc   +1 more source

Sulfated Glycans Inhibit the Interaction of MERS-CoV Receptor Binding Domain with Heparin. [PDF]

Viruses
Yang J, Song Y, Jin W, Xia K, Burnett GC, Qiao W, Bates JT, Pomin VH, Wang C, Qiao M, Linhardt RJ, Dordick JS, Zhang F.   +12 more
europepmc   +1 more source

A multi-antigen vaccinia vaccine broadly protected mice against SARS-CoV-2 and influenza A virus while also targeting SARS-CoV-1 and MERS-CoV. [PDF]

Front Immunol
Gao N, Yang T, Dong L, Tang W, Cao K, Ding L, Zhu C, Bai S, Xia A, Zhu Y, Zhao C, Peng H, Xu J, Zhang X.   +13 more
europepmc   +1 more source

Retracted: Computer-Aided Prediction and Identification of Phytochemicals as Potential Drug Candidates against MERS-CoV. [PDF]

Biomed Res Int
International BR.
europepmc   +1 more source

Inactivated Split MERS-CoV Antigen Prevents Lethal Middle East Respiratory Syndrome Coronavirus Infections in Mice. [PDF]

Vaccines (Basel)
Seo H, Jang Y, Kwak D.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV.

European Review for Medical and Pharmacological Sciences, 2020
OBJECTIVE Human infections with zoonotic coronavirus contain emerging and reemerging pathogenic characteristics which have raised great public health concern.
S. Meo, Alhowikan Am, T. Al-khlaiwi, I. Meo, D. Halepoto, M. Iqbal, A. Usmani, W. Hajjar, Naseer Ahmed   +8 more
semanticscholar   +1 more source

MERS-CoV Infection

2021
Middle East respiratory syndrome coronavirus (MERS-CoV) is an emerging pathogen associated with severe respiratory symptoms and renal failure in infected persons and mild-to-subclinical infection in dromedary camels. MERS-CoV causes nowell-defined disease in camels and its impact of MERS-CoV on animal health is exceptionally low.
openaire   +2 more sources

Managing MERS-CoV in the healthcare setting

Hospital Practice, 2015
Middle East respiratory Syndrome Coronavirus (MERS-CoV) has caused at least 1118 reported cases in 24 countries with at least 423 deaths worldwide. All cases are epidemiologically linked to the Arabian Penninsula with most cases reported from the Kingdom of Saudi Arabia.
Ziad A. Memish, Jaffar A. Al-Tawfiq
openaire   +2 more sources

MERS-CoV: an emerging disease

Independent Nurse, 2014
The latest infectious disease to emerge is Middle East respiratory syndrome, explains Carolyn Driver
openaire   +2 more sources